Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan

Vita Coco Company CEO Martin Roper sold a total of 40,000 shares of common stock across direct and indirect holdings in early October 2025, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Martin Roper, Chief Executive Officer and Director of Vita Coco Company, Inc. (COCO), reported sales of 40,000 shares of common stock.
• The transactions occurred on October 3, 2025, and October 6, 2025.
• All sales were executed under a Rule 10b5-1 trading plan, indicating pre-scheduled transactions.
• Shares were sold at weighted average prices ranging from approximately $42.51 to $42.918 per share.
• The sales included 10,000 shares from direct holdings and 10,000 shares each from the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust.
• Following these transactions, Martin Roper directly holds 288,897 shares of common stock.
• Indirect beneficial ownership after the sales includes 223,406 shares via the Christopher G. Roper Exempt Family Trust, 222,515 shares via the Peter S. Roper Exempt Family Trust, 223,531 shares via the Thomas L. Roper Exempt Family Trust, and 61,200 shares via spouse.
• Roper also holds 1,099,460 non-qualified stock options with various exercise prices and vesting schedules, including 620,620 fully vested options and 478,840 options vesting through March 2026.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider sales can be perceived negatively, the execution under a pre-arranged 10b5-1 trading plan suggests planned diversification rather than a reaction to new negative information. The CEO also retains substantial equity and option holdings, balancing the impact of the sales.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which provides transparency and indicates pre-scheduled transactions, mitigating concerns about opportunistic insider selling.
• Martin Roper retains significant direct and indirect beneficial ownership of common stock, totaling 796,049 shares, demonstrating continued equity alignment with the company.
• Roper holds a substantial number of unexercised non-qualified stock options (1,099,460 shares), with various exercise prices, indicating a continued long-term incentive to enhance shareholder value.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived by the market as a signal of reduced confidence or a desire to diversify holdings, potentially leading to negative sentiment.
• The sales occurred at prices ranging from $41.90 to $43.12, which could be interpreted as management taking profits.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the inherent risks associated with stock ownership and market fluctuations.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
• The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Industry Context

This insider transaction report is specific to the individual holdings of Vita Coco Company's CEO and does not provide information directly related to broader industry trends or the competitive landscape.

Related Party Transactions

• Sales of shares held by the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust, which are indirectly beneficially owned by Martin Roper.

Stakeholder Impact

• Shareholders may interpret the insider sales as a signal, potentially leading to short-term price volatility.
• The use of a 10b5-1 plan provides transparency and predictability regarding executive stock transactions, which can be viewed positively by investors.

Key Dates

Recommendation

While the CEO's sale of shares might typically be viewed negatively, the execution under a Rule 10b5-1 plan suggests a pre-planned diversification strategy rather than a reaction to new adverse company developments. The CEO retains substantial direct and indirect equity holdings, along with significant unexercised stock options, indicating continued alignment with the company's long-term performance. Without additional financial or operational updates, this Form 4 alone does not provide sufficient grounds for a 'buy' or 'sell' recommendation, thus a 'hold' stance is appropriate.

Keywords

Vita Coco Company, COCO, Martin Roper, Insider Trading, Form 4, Stock Sales, 10b5-1 Plan, Executive Compensation, Equity Holdings, Coconut Water